Skip to main content
Top
Published in: Supportive Care in Cancer 7/2009

01-07-2009 | Review Article

Continued success of the rapid response radiotherapy program: a review of 2004–2008

Authors: Eric de Sa, Emily Sinclair, Gunita Mitera, Jennifer Wong, Cyril Danjoux, Amanda Hird, Stephanie Hadi, Elizabeth Barnes, May Tsao, Edward Chow

Published in: Supportive Care in Cancer | Issue 7/2009

Login to get access

Abstract

Purpose

To update the clinical activity of the Rapid Response Radiotherapy Program (RRRP).

Materials and methods

We conducted a retrospective review of our clinic database from January 2004 until July 2008. The number of patients referred to the RRRP, relevant demographic data, diagnosis and treatment dispositions were recorded. Time interval between referral to consultation and consultation to simulation were also calculated.

Results

During the study period, 3,267 patients were seen in the RRRP. Forty-five percent (1,494) of the patients were new to the clinic. Of the 3,267 patients seen, 1,548 (47.4%) were female and 1,719 (52.6%) were male. The median age was 69.2 years (range, 22–101 years). The most common primary sites were lung (34.2%), breast (21.2%) and prostate (17.0%). The majority of patients were referred for palliative treatment of bone metastases (52.4%) or treatment for brain metastases (20.7%). Of the patients referred, 2,311 (70.5%) patients received palliative radiotherapy. The median duration from referral to consultation was 4 days. The majority (82.3%) of patients were simulated and treated within the first 7 days following consultation.

Conclusion

The number of patients referred to the RRRP from January 2004–July 2008 remains comparable to our previous report (1996–2003). The overall median interval from referral to consultation for the analysed time period was 4 days. Therefore, we are continuing to meet our goal of providing rapid access to palliative radiation treatment for symptomatic cancer patients. Further information relating to progression and advancements within the clinic aimed at improving our patients’ quality of life are explored.
Literature
1.
go back to reference Rutten EH, Crul BJ, van der Toorn PP, Otten AW, Dirksen R (1997) Pain characteristics help to predict the analgesic efficacy of radiotherapy for the treatment of cancer pain. Pain 69:131–135PubMedCrossRef Rutten EH, Crul BJ, van der Toorn PP, Otten AW, Dirksen R (1997) Pain characteristics help to predict the analgesic efficacy of radiotherapy for the treatment of cancer pain. Pain 69:131–135PubMedCrossRef
2.
go back to reference Chow E, Wong R, Connolly R, Hruby G, Franssen E, Fung K, Vachon M, Anderson L, Pope J, Holden L, Szumacher E, Schueller T, Stefaniuk K, Finkelstein J, Hayter C, Danjoux C (2001) Prospective assessment of symptom palliation for patients attending a rapid response radiotherapy program: feasibility of telephone follow-up. J Pain Symptom Manage 22(2):649–656PubMedCrossRef Chow E, Wong R, Connolly R, Hruby G, Franssen E, Fung K, Vachon M, Anderson L, Pope J, Holden L, Szumacher E, Schueller T, Stefaniuk K, Finkelstein J, Hayter C, Danjoux C (2001) Prospective assessment of symptom palliation for patients attending a rapid response radiotherapy program: feasibility of telephone follow-up. J Pain Symptom Manage 22(2):649–656PubMedCrossRef
3.
go back to reference Ash DV (2000) Waiting times for cancer treatment. Clin Oncol 12(3):140 Ash DV (2000) Waiting times for cancer treatment. Clin Oncol 12(3):140
4.
go back to reference Danjoux C, Szumacher E, Andersson L, Franssen E, Wong R, Chow E, Connolly R, Pope J, Hayter CR, Finkelstein J, Axelrod T, Stephen D, Sixel K, Thomas G, Schueller T, Stefaniuk K (2000) Palliative radiotherapy at Toronto-Sunnybrook regional cancer centre: the rapid response radiotherapy program. Curr Oncol 7(1):52–56 Danjoux C, Szumacher E, Andersson L, Franssen E, Wong R, Chow E, Connolly R, Pope J, Hayter CR, Finkelstein J, Axelrod T, Stephen D, Sixel K, Thomas G, Schueller T, Stefaniuk K (2000) Palliative radiotherapy at Toronto-Sunnybrook regional cancer centre: the rapid response radiotherapy program. Curr Oncol 7(1):52–56
5.
go back to reference Hoegler D (1997) Design and assessment of palliative radiotherapy service structure to patients and referring physician need. Clin Invest Med A 463(Suppl 20):S84 Hoegler D (1997) Design and assessment of palliative radiotherapy service structure to patients and referring physician need. Clin Invest Med A 463(Suppl 20):S84
6.
go back to reference Danjoux C, Chow E, Drossos A, Holden L, Hayter C, Tsao M, Barnes T, Sinclair E, Farhadian M (2006) An innovative rapid response radiotherapy program to reduce waiting time for palliative radiotherapy. Support Care Cancer 14:38–43PubMedCrossRef Danjoux C, Chow E, Drossos A, Holden L, Hayter C, Tsao M, Barnes T, Sinclair E, Farhadian M (2006) An innovative rapid response radiotherapy program to reduce waiting time for palliative radiotherapy. Support Care Cancer 14:38–43PubMedCrossRef
7.
go back to reference Lehman M, Jacob S, Delaney G, Papadatos G, Jalaludin B, Cail S, McCourt J, Wright S, O’Brien C, Barton M (2004) Waiting times for radiotherapy—a survey of patients’ attitudes. Radiother Oncol 70:283–289PubMedCrossRef Lehman M, Jacob S, Delaney G, Papadatos G, Jalaludin B, Cail S, McCourt J, Wright S, O’Brien C, Barton M (2004) Waiting times for radiotherapy—a survey of patients’ attitudes. Radiother Oncol 70:283–289PubMedCrossRef
9.
go back to reference Chow E, Fung KW, Panzarella T, Bezjak A, Danjoux C, Tannock I (2002) A predictive model for survival in metastatic cancer patients attending an outpatient palliative radiotherapy clinic. Int J Radiat Oncol Biol Phys 53(5):1291–1302PubMedCrossRef Chow E, Fung KW, Panzarella T, Bezjak A, Danjoux C, Tannock I (2002) A predictive model for survival in metastatic cancer patients attending an outpatient palliative radiotherapy clinic. Int J Radiat Oncol Biol Phys 53(5):1291–1302PubMedCrossRef
10.
go back to reference Andersson L, Chow E, Finkelstein J, Connolly R, Danjoux C, Szumacher E, Wong R, Stephen D, Axelrod T (1999) The ultimate one-stop for cancer patients with bone metastases: new combined bone metastases clinic. Can Oncol Nurs J 9(2):103–104PubMed Andersson L, Chow E, Finkelstein J, Connolly R, Danjoux C, Szumacher E, Wong R, Stephen D, Axelrod T (1999) The ultimate one-stop for cancer patients with bone metastases: new combined bone metastases clinic. Can Oncol Nurs J 9(2):103–104PubMed
Metadata
Title
Continued success of the rapid response radiotherapy program: a review of 2004–2008
Authors
Eric de Sa
Emily Sinclair
Gunita Mitera
Jennifer Wong
Cyril Danjoux
Amanda Hird
Stephanie Hadi
Elizabeth Barnes
May Tsao
Edward Chow
Publication date
01-07-2009
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 7/2009
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-009-0585-7

Other articles of this Issue 7/2009

Supportive Care in Cancer 7/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine